WallStreetZenWallStreetZen

NASDAQ: PACB
Pacific Biosciences Of California Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for PACB

Based on 11 analysts offering 12 month price targets for Pacific Biosciences Of California Inc.
Min Forecast
$2.50+71.23%
Avg Forecast
$7.77+432.4%
Max Forecast
$15.00+927.4%

Should I buy or sell PACB stock?

Based on 11 analysts offering ratings for Pacific Biosciences Of California Inc.
Buy
Strong Buy
5 analysts 45.45%
Buy
2 analysts 18.18%
Hold
4 analysts 36.36%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their PACB stock forecasts and price targets.

PACB stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-18Find Out Why
lockedlocked$00.00+00.00%2024-04-18Find Out Why
lockedlocked$00.00+00.00%2024-04-18Find Out Why
lockedlocked$00.00+00.00%2024-04-17Find Out Why
lockedlocked$00.00+00.00%2024-04-10
UBS
Bottom 4%
4
Strong BuyMaintains$12.00+721.92%2024-02-16
Stephens & Co.
Bottom 8%
8
Strong BuyInitiates Coverage On$11.00+653.42%2023-12-14
Piper Sandler
Top 16%
85
HoldMaintains$8.00+447.95%2023-11-06
Canaccord Genuity
Bottom 5%
5
Strong BuyMaintains$15.00+927.40%2023-10-31
Cantor Fitzgerald
Bottom 8%
8
Strong BuyUpgrades$11.00+653.42%2023-10-31

1 of 2

Forecast return on equity

Is PACB forecast to generate an efficient return?
Company
N/A
Industry
-0.03%
Market
20.1%

Forecast return on assets

Is PACB forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.02%

PACB revenue forecast

What is PACB's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$237.1M+18.25%
Avg 2 year Forecast
$360.8M+79.93%
Avg 3 year Forecast
$504.3M+151.47%
PACB's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

PACB revenue growth forecast

How is PACB forecast to perform vs Medical Devices companies and vs the US market?
Company
35.29%
Industry
8.7%
Market
9.39%
PACB's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
PACB's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

PACB vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
PACB$1.46$7.77+432.40%Buy
NPCE$14.00$17.00+21.43%Strong Buy
MXCT$3.88$8.67+123.38%Strong Buy
ANIK$25.43$29.50+16.00%Buy
SRDX$26.39$59.00+123.57%Buy
View Top Medical Device Stocks

Pacific Biosciences Of California Stock Forecast FAQ

Is Pacific Biosciences Of California Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 11 Wall Street analysts covering (NASDAQ: PACB) stock is to Buy PACB stock.

Out of 11 analysts, 5 (45.45%) are recommending PACB as a Strong Buy, 2 (18.18%) are recommending PACB as a Buy, 4 (36.36%) are recommending PACB as a Hold, 0 (0%) are recommending PACB as a Sell, and 0 (0%) are recommending PACB as a Strong Sell.

If you're new to stock investing, here's how to buy Pacific Biosciences Of California stock.

What is PACB's revenue growth forecast for 2024-2026?

(NASDAQ: PACB) Pacific Biosciences Of California's forecast annual revenue growth rate of 35.29% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.7%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.39%.

Pacific Biosciences Of California's revenue in 2024 is $200,521,000.On average, 4 Wall Street analysts forecast PACB's revenue for 2024 to be $63,534,070,267, with the lowest PACB revenue forecast at $61,494,956,460, and the highest PACB revenue forecast at $65,085,511,652. On average, 4 Wall Street analysts forecast PACB's revenue for 2025 to be $96,674,090,833, with the lowest PACB revenue forecast at $90,353,373,936, and the highest PACB revenue forecast at $105,723,093,773.

In 2026, PACB is forecast to generate $135,116,611,153 in revenue, with the lowest revenue forecast at $125,160,323,148 and the highest revenue forecast at $143,745,465,545.

What is PACB's forecast return on assets (ROA) for 2024-2026?

(NASDAQ: PACB) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of -0.02%.

What is PACB's Price Target?

According to 11 Wall Street analysts that have issued a 1 year PACB price target, the average PACB price target is $7.77, with the highest PACB stock price forecast at $15.00 and the lowest PACB stock price forecast at $2.50.

On average, Wall Street analysts predict that Pacific Biosciences Of California's share price could reach $7.77 by Apr 18, 2025. The average Pacific Biosciences Of California stock price prediction forecasts a potential upside of 432.4% from the current PACB share price of $1.46.

What is PACB's forecast return on equity (ROE) for 2024-2026?

(NASDAQ: PACB) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.